These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 17485856)
61. Plasminogen activation by staphylokinase enhances local spreading of S. aureus in skin infections. Peetermans M; Vanassche T; Liesenborghs L; Claes J; Vande Velde G; Kwiecinksi J; Jin T; De Geest B; Hoylaerts MF; Lijnen RH; Verhamme P BMC Microbiol; 2014 Dec; 14():310. PubMed ID: 25515118 [TBL] [Abstract][Full Text] [Related]
62. Platelet Membrane-Coated r-SAK Improves Thrombolytic Efficacy by Targeting Thrombus. Hua R; Li M; Lin Q; Dong M; Gong X; Lin Z; Li Y; Li C; Wu T; Tan C; Zhang W; Wang Q; Wu T; Zhou X; Yang F; Li C ACS Appl Mater Interfaces; 2024 May; 16(17):21438-21449. PubMed ID: 38626407 [TBL] [Abstract][Full Text] [Related]
63. Kinetic properties of the activator complexes plasmin--staphylokinase and plasmin(ogen)--streptokinase in vitro. Sazonova IY; Aisina RB; Muhametova LI; Varfolomeyev SD Biochemistry (Mosc); 1999 Jan; 64(1):66-74. PubMed ID: 9986915 [TBL] [Abstract][Full Text] [Related]
64. Structure-function relationships in staphylokinase as revealed by "clustered charge to alanine" mutagenesis. Silence K; Hartmann M; Gührs KH; Gase A; Schlott B; Collen D; Lijnen HR J Biol Chem; 1995 Nov; 270(45):27192-8. PubMed ID: 7592976 [TBL] [Abstract][Full Text] [Related]
65. Activation of plasminogen by staphylokinase reduces the severity of Staphylococcus aureus systemic infection. Kwieciński J; Josefsson E; Mitchell J; Higgins J; Magnusson M; Foster T; Jin T; Bokarewa M J Infect Dis; 2010 Oct; 202(7):1041-9. PubMed ID: 20726765 [TBL] [Abstract][Full Text] [Related]
66. Structural and functional characterization of recombinant mouse annexin A11: influence of calcium binding. Lecona E; Turnay J; Olmo N; Guzmán-Aránguez A; Morgan RO; Fernandez MP; Lizarbe MA Biochem J; 2003 Jul; 373(Pt 2):437-49. PubMed ID: 12689336 [TBL] [Abstract][Full Text] [Related]
67. Enhanced plasminogen activation by staphylokinase in the presence of streptokinase beta/betagamma domains: plasminogen kringles play a role. Dahiya M; Rajamohan G; Dikshit KL FEBS Lett; 2005 Mar; 579(7):1565-72. PubMed ID: 15757642 [TBL] [Abstract][Full Text] [Related]
68. Prourokinase-annexin V chimeras. Construction, expression, and characterization of recombinant proteins. Tait JF; Engelhardt S; Smith C; Fujikawa K J Biol Chem; 1995 Sep; 270(37):21594-9. PubMed ID: 7665573 [TBL] [Abstract][Full Text] [Related]
69. Interactions of staphylokinase with human platelets. Lijnen HR; Van Hoef B; Collen D Thromb Haemost; 1995 Mar; 73(3):472-7. PubMed ID: 7667831 [TBL] [Abstract][Full Text] [Related]
70. Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin. Hunt JA; Petteway SR; Scuderi P; Novokhatny V Thromb Haemost; 2008 Sep; 100(3):413-9. PubMed ID: 18766256 [TBL] [Abstract][Full Text] [Related]
71. In vitro characterization of a multifunctional staphylokinase variant with reduced reocclusion, produced from salt inducible E. coli GJ1158. Pulicherla KK; Kumar A; Gadupudi GS; Kotra SR; Rao KR Biomed Res Int; 2013; 2013():297305. PubMed ID: 23998121 [TBL] [Abstract][Full Text] [Related]
72. A novel variant of staphylokinase gene from Staphylococcus aureus ATCC 29213. Kim SH; Chun HS; Han MH; Park NY; Suk K Thromb Res; 1997 Aug; 87(4):387-95. PubMed ID: 9271816 [TBL] [Abstract][Full Text] [Related]
73. Construction of a novel Staphylokinase (SAK) mutant with low immunogenicity and its evaluation in rhesus monkey. Wang M; Chen Y; Fu W; Zou M; Wang Y; Xing W; Wang J; Xu D Int J Biol Macromol; 2020 Mar; 146():781-789. PubMed ID: 31730959 [TBL] [Abstract][Full Text] [Related]
74. Structural determinants for plant annexin-membrane interactions. Dabitz N; Hu NJ; Yusof AM; Tranter N; Winter A; Daley M; Zschörnig O; Brisson A; Hofmann A Biochemistry; 2005 Dec; 44(49):16292-300. PubMed ID: 16331990 [TBL] [Abstract][Full Text] [Related]
75. Comparative effects of staphylokinase and alteplase in rabbit bleeding time models. Vanderschueren S; Collen D Thromb Haemost; 1996 May; 75(5):816-9. PubMed ID: 8725729 [TBL] [Abstract][Full Text] [Related]
76. Preparation and characterization of a disulfide-linked bioconjugate of annexin V with the B-chain of urokinase: an improved fibrinolytic agent targeted to phospholipid-containing thrombi. Tanaka K; Einaga K; Tsuchiyama H; Tait JF; Fujikawa K Biochemistry; 1996 Jan; 35(3):922-9. PubMed ID: 8547274 [TBL] [Abstract][Full Text] [Related]
77. Staphylokinase has distinct modes of interaction with antimicrobial peptides, modulating its plasminogen-activation properties. Nguyen LT; Vogel HJ Sci Rep; 2016 Aug; 6():31817. PubMed ID: 27554435 [TBL] [Abstract][Full Text] [Related]
78. Structure-based antigenic epitope and PEGylation improve the efficacy of staphylokinase. Xu Y; Shi Y; Zhou J; Yang W; Bai L; Wang S; Jin X; Niu Q; Huang A; Wang D Microb Cell Fact; 2017 Nov; 16(1):197. PubMed ID: 29137636 [TBL] [Abstract][Full Text] [Related]
79. Guiding a docking mode by phage display: selection of correlated mutations at the staphylokinase-plasmin interface. Jespers L; Lijnen HR; Vanwetswinkel S; Van Hoef B; Brepoels K; Collen D; De Maeyer M J Mol Biol; 1999 Jul; 290(2):471-9. PubMed ID: 10390345 [TBL] [Abstract][Full Text] [Related]
80. Crystal structure of a staphylokinase: variant a model for reduced antigenicity. Chen Y; Song G; Jiang F; Feng L; Zhang X; Ding Y; Bartlam M; Yang A; Ma X; Ye S; Liu Y; Tang H; Song H; Rao Z Eur J Biochem; 2002 Jan; 269(2):705-11. PubMed ID: 11856331 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]